Loading
SL
SteadyMed Ltd. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by STARK BRIAN JAY, was filed 22 Aug 2017.
SteadyMed Ltd.: what insiders have been doing
This page follows insider dealings at SteadyMed Ltd. as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for SteadyMed Ltd. The previous disclosure was published on 7 September 2018.
The full history, which starts in 2016, counts 7 purchases against 27 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
41
Thresholds
n/a
Buy Volume
€11M
7 ops. · all time
Sell Volume
€51M
27 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
RevenueUS$949.3k
Net income-US$20.7M-2178.9% margin
Last declaration on 7 September 2018
Declarations41 total
2,123,098 shares@ US$4.46100.0% of flowOrdinary Shares, nominal value NIS 0.01 per shareSEC:0000947871-18-000735:0
266,257 shares@ US$4.4610.5% of flowOrdinary SharesSEC:0001209191-18-049379:0
2,088,258 shares@ US$4.4682.4% of flowOrdinary SharesSEC:0001209191-18-049379:1
181,025 shares@ US$4.467.1% of flowOrdinary SharesSEC:0001209191-18-049379:2
1,045,816 shares@ US$4.4689.6% of flowOrdinary SharesSEC:0001209191-18-049378:0
105,306 shares@ US$4.469.0% of flowOrdinary SharesSEC:0001209191-18-049378:1
16,298 shares@ US$4.461.4% of flowOrdinary SharesSEC:0001209191-18-049378:2
22,157 shares@ US$4.4649.8% of flowOrdinary SharesSEC:0001209191-18-049373:0
29,830 shares@ US$4.461.2% of flowOrdinary SharesSEC:0001209191-18-049381:0
266,257 shares@ US$4.4610.3% of flowOrdinary SharesSEC:0001209191-18-049381:1
2,088,258 shares@ US$4.4680.6% of flowOrdinary SharesSEC:0001209191-18-049381:2
25,000 shares@ US$4.461.0% of flowOrdinary SharesSEC:0001209191-18-049381:3
181,025 shares@ US$4.467.0% of flowOrdinary SharesSEC:0001209191-18-049381:4
2,937,938 shares@ US$4.4662.5% of flowOrdinary SharesSEC:0001209191-18-049380:0
1,166,428 shares@ US$4.4624.8% of flowOrdinary SharesSEC:0001209191-18-049380:1
15,780 shares@ US$4.460.3% of flowOrdinary SharesSEC:0001209191-18-049380:2
253,309 shares@ US$4.465.4% of flowOrdinary SharesSEC:0001209191-18-049380:3
323,500 shares@ US$4.466.9% of flowOrdinary SharesSEC:0001209191-18-049380:4
41,605 shares@ US$4.4611.4% of flowOrdinary SharesSEC:0001209191-18-049375:0
4,960 shares@ US$4.461.4% of flowOrdinary SharesSEC:0001209191-18-049375:1
44,242 shares@ US$2.747.5% of flowOrdinary SharesSEC:0001562180-18-003770:0
44,242 shares@ US$4.7313.0% of flowOrdinary SharesSEC:0001562180-18-003770:1
16,994 shares@ US$2.742.9% of flowOrdinary SharesSEC:0001562180-18-003770:2
16,994 shares@ US$4.705.0% of flowOrdinary SharesSEC:0001562180-18-003770:3
88,831 shares@ US$4.6626.1% of flowOrdinary SharesSEC:0001562180-18-003675:0
25 of 41 declarations
About SteadyMed Ltd.
SteadyMed Ltd. is a company focused on developing innovative pharmaceutical treatments. It is listed on the XNAS market.
